Evidence map›Paper›PMID 38443062›Full record

ArticleThe journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians2024

Variation in prenatal surveillance and management of anti-SSA/Ro autoantibody positive pregnancies.

Lisa W Howley, Stephanie A Eyerly-Webb, Stacy A S Killen, Erin Paul, Anita Krishnan, Melanie R F Gropler, Bailey Drewes, Eric Dion, Amy Lund, Jill P Buyon and 1 more

Open access · diamondAbstract read
In one paragraph

Article in The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Reproductive Health in Scleroderma, Vasculitis, and Sjögren Syndrome.Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases · 2024
    Review
  3. Diagnosis and Management of Fetal Arrhythmias in the Current Era.Journal of cardiovascular development and disease · 2024
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 1 country.

Lisa W HowleyMidwest Fetal Care Center, Children's Minnesota, Minneapolis, MN, USA.ORCID 0000-0002-3617-4331
Stephanie A Eyerly-WebbMidwest Fetal Care Center, Children's Minnesota, Minneapolis, MN, USA.ORCID 0000-0002-0377-1148
Stacy A S KillenVanderbilt University Medical Center, Monroe Carell Jr. Children's Hospital, Nashville, TN, USA.
Erin PaulIcahn School of Medicine, Mount Sinai Children's Heart Center, New York, NY, USA.
Anita KrishnanChildren's National Hospital, Washington, DC, USA.
Melanie R F GroplerPhoenix Children's Hospital, Phoenix, AZ, USA.
Bailey DrewesUniversity of Colorado School of Medicine, Aurora, CO, USA.
Eric DionMidwest Fetal Care Center, Children's Minnesota, Minneapolis, MN, USA.
Amy LundMidwest Fetal Care Center, Children's Minnesota, Minneapolis, MN, USA.
Jill P BuyonNew York University Grossman School of Medicine, NYU Langone Medical Center, New York, NY, USA.ORCID 0000-0002-3852-7129
Bettina F CuneoUniversity of Colorado School of Medicine, Aurora, CO, USA.ORCID 0000-0001-9085-0882
Children's Minnesota · USChildren’s Minnesota - St. Paul Hospital · USUniversity of Colorado Denver · USChildren's National · USIcahn School of Medicine at Mount Sinai · USMonroe Carell Jr. Children's Hospital · USNYU Langone Health · USPhoenix Children's Hospital · US

Funding

Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)R01HD100929 · NICHD · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BUYON, JILL P, CUNEO, BETTINA FRANCESCA · 2020 to 2024
$3.5M
NICHD NIH HHS R01 HD100929
6 · The paper itself

Abstract

objectiveTo describe international surveillance and treatment strategies for managing anti-SSA/Ro autoantibody positive pregnancies. STUDY

designAn electronic REDCap questionnaire was distributed to Fetal Heart Society and North American Fetal Therapy Network members which queried institution-based risk stratification, surveillance methods/frequency, conduction abnormality treatments, and postnatal anti-SSA/Ro pregnancy assessment.

results101 responses from 59 centers (59% US, 17% international) were collected. Most (79%) do not risk stratify pregnancies by anti-SSA/Ro titer; those that do use varied cutoff values. Many pregnant rheumatology patients are monitored for cardiac abnormalities regardless of maternal anti-SSA/Ro status. Surveillance strategies were based on maternal factors (anti-SSA/Ro status 85%, titer 25%, prior affected child 79%) and monitoring durations varied. Most respondents treat 2° and 3° fetal atrioventricular block, commonly with dexamethasone and/or IVIG.

conclusionsWide variation exists in current fetal cardiac surveillance and treatment for anti-SSA/Ro autoantibody positive pregnancies, highlighting the need for evidence-based protocols to optimize care.

Indexed as

Atrioventricular BlockAutoantibodiesChildFemaleFetal HeartHealth FacilitiesHumansPregnancyPrenatal CareVitaminsAutoantibodiesVitaminsAnti-SSA/Ro autoantibodyheart blockpregnancyrheumatic diseaserisk stratificationtiter

Identifiers

PMID38443062
PMCPMC11005667
OpenAlexW4392844280

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.